-transparent.png){kind=logo}
In a randomized, two-fold cross-over design 12 healthy volunteers received a normal-release 10 mg nifedipine soft gelatine capsule (Pidilat or a marketed product, respectively). The quantitative determination of the drug in plasma was achieved by gas chromatography up to 24 h p.a. Some important pharmacokinetic parameters and the relative bioavailabilities of the preparations were calculated and subsequently compared statistically: statistically significant differences between the preparations could not be found. Mean peak plasma concentrations of 121.2 +/- 47.3 and 104.5 +/- 32.9 ng/ml were reached approximately 0.5 h p.a. Both plasma level curves were practically identical, with the exception of the obtained absolute peak plasma concentrations. The known strong inter- and intraindividual variations of the plasma levels were found to be less pronounced in this study.
W Dahmen, and
G Pabst, and
K H Molz, and
D Lutz, and
H Jaeger
February 1988,
Arzneimittel-Forschung,
W Dahmen, and
G Pabst, and
K H Molz, and
D Lutz, and
H Jaeger
January 1979,
British journal of clinical pharmacology,
W Dahmen, and
G Pabst, and
K H Molz, and
D Lutz, and
H Jaeger
January 1993,
Pharmacotherapy,
W Dahmen, and
G Pabst, and
K H Molz, and
D Lutz, and
H Jaeger
March 1976,
Journal of pharmaceutical sciences,
W Dahmen, and
G Pabst, and
K H Molz, and
D Lutz, and
H Jaeger
August 2000,
Pharmaceutical research,
W Dahmen, and
G Pabst, and
K H Molz, and
D Lutz, and
H Jaeger
December 1989,
Arzneimittel-Forschung,
W Dahmen, and
G Pabst, and
K H Molz, and
D Lutz, and
H Jaeger
December 1977,
European journal of clinical pharmacology,
W Dahmen, and
G Pabst, and
K H Molz, and
D Lutz, and
H Jaeger
October 2010,
Journal of pharmaceutical sciences,
W Dahmen, and
G Pabst, and
K H Molz, and
D Lutz, and
H Jaeger
February 1992,
The Annals of pharmacotherapy,
W Dahmen, and
G Pabst, and
K H Molz, and
D Lutz, and
H Jaeger
February 1978,
Bollettino chimico farmaceutico,
